Package 62372-541-12

{"route": ["ORAL"], "spl_id": "10a66d74-74b5-3f8d-e063-6394a90a7f00", "openfda": {"nui": ["N0000010282"], "unii": ["H0G9379FGK", "92RU3N3Y1O", "NBZ3QY004S"], "rxcui": ["1788932"], "spl_set_id": ["10a66d74-74b4-3f8d-e063-6394a90a7f00"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "manufacturer_name": ["Infirst Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "355 mL in 1 BOTTLE (62372-541-12)", "package_ndc": "62372-541-12", "marketing_start_date": "20240131"}], "brand_name": "Mylanta Vanilla Caramel", "product_id": "62372-541_10a66d74-74b5-3f8d-e063-6394a90a7f00", "dosage_form": "LIQUID", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Skin Barrier Activity [PE]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "62372-541", "generic_name": "Calcium carbonate, magnesium hydroxide, simethicone", "labeler_name": "Infirst Healthcare Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mylanta Vanilla Caramel", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/10mL"}, {"name": "DIMETHICONE", "strength": "80 mg/10mL"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "270 mg/10mL"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240131", "listing_expiration_date": "20261231"}